This Notice of Special Interest (NOSI) is to alert the community that the National Cancer Institute (NCI) Center for Global Health (CGH) is seeking to leverage ongoing Innovative Molecular Analysis Technologies (IMAT) program activities to stimulate exploratory research on technology platforms relevant for global oncology and appropriate for use in low-resource settings globally. NCI CGH is prepared to support highly meritorious R21 applications submitted to either RFA-CA-21-003 or RFA-CA-21-005, with the goal of helping drive innovation in this field and enrich the pool of investigators participating in the NCI-sponsored Affordable Cancer Technologies (ACTs) Program.

Both RFA-CA-21-003 and RFA-CA-21-005 solicit grant applications proposing exploratory research projects focused on the early-stage development of innovative technologies for basic and clinical cancer research. Projects in response to this Notice of Special Interest should address topics within the scientific scope of these IMAT R21 RFAs.

Deadlines:

• Letters of Intent Receipt Date(s): 30 days before the application due date
• Application Due Date(s): February 22, 2021; May 27, 2021; September 29, 2021

NOT-CA-21-025